Posts Tagged ‘LF’

Reading List – 3/9/2010

March 9th, 2010

Hello everybody! Today we’re reading about GlaxoSmithKline upping its efforts to fight lymphatic filariasis, a new treatment for American soldiers who caught cutaneous leishmaniasis in Iraq, the latest release on the fight against LF in India, and, on a different note, a group of ultra-Orthodox rabbis declaring that lox should no longer be considered kosher due to a variant of roundworm found in fish.

In tough climate, GSK dedicates plant to fight elephantiasis, Rick Smith, Localtechwire

Heat therapy shown effective in treating cutaneous leishmaniasis among US soldiers in Iraq, PLoS Neglected Tropical Diseases

DMO allays fears over DEC tablets, The Hindu

Rabbis Claim Lox No Longer Kosher, Erica Butler, NBC New York

Reading List 3/2/10

March 2nd, 2010

Here’s what we’re reading today:

Trachoma casts shadow over Aboriginal communities, Australian Broadcast Corporation

Chagas disease surveillance focuses on palms, undercover bugs, Beth King, Smithsonian Tropical Research Institute

ADRA and Guyanese Government Partner to Combat Parasitic Diseases, Nadia McGill, Reuters

Reading List – 2/22/10

February 22nd, 2010

Not much to read today, but there’s still some important stuff out there. Today we’re reading about an anti-lymphatic filariasis effort in Nepal and an update on the fight against Guinea worm.

Free drugs of Filariasis distributed in Kaski, The Rising Nepal

Carter: Eradication of Guinea Worm Disease Near in Sudan, Sheila Poole, Atlanta Journal-Constitution

Night 4: Lymphatic Filariasis

December 15th, 2009

By Fr. Tom Streit, Director–University of Notre Dame Haiti Program, on behalf of those working on LF in Haiti

The program to eliminate lymphatic filariasis (LF) is the largest public health program you never heard about.  In fact, most people who work in global health are shocked when they hear that more than 500 million people in over 40 countries were treated last year.  That is an impressive number, but it still represents less than one half of the total number that will need to receive annual treatment (for five or more years) if LF is to be eliminated.

These parasites are transmitted by mosquitoes and are best recognized as a cause of elephantiasis.  Adult worms live in the lymphatic vessels in humans and the female worms release motile stages called microfilaria into the blood.  It is this stage that is picked up by mosquitoes when the mosquito takes a blood meal.  After maturation in the mosquito, a process that takes one to two weeks, the larval stage is ready to infect another person during a blood meal.  For most people, the infection has no apparent symptoms, but some are incapacitated.  People with elephantiasis or men with scrotal swelling (also called hydrocele) can be so disabled by LF that they are unable to work or support their families.  They are often ostracized in their communities because of the fear and misunderstanding about the cause of the disease.

clean Antoine

As scientists, we continue to be fascinated by these parasites at the same time we have committed to getting rid of them.  I recognize the paradox here, but if we can reduce the suffering associated with LF and other NTDs, we should, even if it leaves the scientific community with a number of unanswered questions, including a few I’d like to share with you.

In many parts of the world, the microfilaria stage of the parasite is only found in the blood at night – when the mosquitoes are most likely to take a blood meal.  How does this work?  What signals is the parasite using to do this?

Why do only a relatively small percentage of people get elephantiasis?  We know that elephantiasis tends to occur in families, but why?  Is this related to genetic effects, environmental conditions or a combination?  Why does the parasite disappear from most of these people as the swelling develops?

On the opposite side of that question, why are some people more likely to acquire infection and maintain microfilaria in their blood for years or decades?  How does the worm avoid the host immune response?  For LF and many infections, we believe that children are more likely to acquire infection if their mothers were infected during pregnancy.  How does this affect other immune responses?

In truth, we don’t need to know the answers to these questions to eliminate LF.  China and Korea have succeeded; we also know that LF disappears on its own following economic development as it did in the United States.  We are now faced with an historic opportunity – as with small pox and now polio and guinea worm – to make a conscious effort to remove the threat of LF permanently.  I, for one, can live with unanswered questions.

International Day of Persons with Disabilities

December 3rd, 2009

In the global health community there is so much focus on death–deaths caused by a disease, deaths averted by an intervention, deaths prevented through programming–that we often forget that over a billion people continue to live each day with disability from infection, injury, and illness.  At the Global Network, we frequently talk about the burden of NTDs in terms of DALYs, or disability-adjusted life years–years of potential life lost due to premature mortality and the years of productive life lost due to disability–because while NTDs do not frequently kill those infected, they are horrifically disabling.

Today, on the UN-designated International Day of Persons with Disabilities, we want to share a few stories of NTDs’ disabling impact, as a reminder that death is only part of the global health story.  Just as importantly, though, we want so share the good news–that in each of these cases, treatment is widely available and incredibly inexpensive.

disfiguring

soil transmitted helminth infectionsOncho

Anjani: As she collected drinking water alongside other children on the banks of a river in southern Nigeria, Ajani had no idea that the water running through her village bred flies that would infect her with a disfiguring and disabling condition. By the age of six, Ajani had contracted onchocerciasis. This disease, commonly called river blindness, infects 37 million of the world’s most vulnerable people and causes partial and often complete blindness, oozing infections of the eyes, and immeasurable itching and pain. People in this part of Africa say ‘the river eats your eyes;’ in some communities, nearly 15% of the population is blind, with as many as 40% of adults visually impaired, robbing many of their livelihoods and condemning entire communities to a continued cycle of poverty and disease.

  • The good news: Within just four years of receiving her first annual treatment (donated by Merck & Co.), her skin was completely cleared of lesions. Her husband came back, pleading with his father-in-law for her return. Today, villagers from surrounding communities seek Ajani out, eager to learn how her beautiful skin was miraculously restored. Best of all, Ajani’s village requested that she become the local distributor for Mectizan, elevating her status, helping her deliver essential aid to the community, and transforming her into a valued spokeswoman for change.

» Read more: International Day of Persons with Disabilities

Clearing the Air on MDA

November 19th, 2009

Last night, Alanna Shaikh of Global Health Basics brought an interesting article to our attention: following mass drug administration (MDA) to treat lymphatic filariasis in Indonesia, “…nine people were dead last week and nearly 1,000 had fallen ill with symptoms such as nausea, dizziness, muscle soreness and vomiting. Hundreds were hospitalized.” She rightfully asked us, “what happened here?”

As it turns out–and it’s a topic we don’t cover much on our blog or website–these symptoms, even for populations in the thousands, are to be expected for MDA.  Like treatment for many other NTDs, when you treat for LF with the drugs DEC and albendazole, infected people will commonly exhibit symptoms including headache, nausea, and fever; those who are uninfected will likely experience minimal side effects.  Additionally, when treating populations en masse, it is probable that some may die from other causes within the treatment period; the correlation between receiving NTD treatment and death may just be coincidental or related to un-screened conditions.

The fear and hysteria that occurred in Indonesia is a reminder that effective media, education, and sensitization campaigns are critical in ensuring a successful MDA campaign.  We are fortunate to have drugs that are safe and effective for wide population demographics, but individuals and communities must feel comfortable taking the drugs and must anticipate the (highly normal) side-effects if we expect them to return in the coming years for treatment.

Professor Yunus and 10 Cups of Tea in Bangladesh

November 5th, 2009

A travel journal entry from Kari Stoever, Managing Director of the Global Network

We’ve just returned from the Global Network’s first trip to Bangladesh, where the tradition is to conduct meetings over a cup of tea.  So, it was naturally over a cup of tea that my team and I first met with Nobel Prize winner Professor Mohammad Yunus about the enormous disease burden caused by NTDs in his country – where as many as 100 million people require treatment annually.

Professor Yunus speaks at a dinner ahead of his meeting with the Global Network team in Bangladesh

Professor Yunus speaks at a dinner ahead of his meeting with the Global Network team in Bangladesh

And it was over tea with public health officials and global health partners that we heard about the challenges facing Bangladesh in their fight against NTDs.  Consider that the country is a little smaller than the state of Iowa, yet has half of the entire US population living in that space; then consider that more than five million people are suffering from the debilitating and stigmatizing effects of lymphatic filariasis (LF), such as elephantiasis, and that many children are suffering from anemia and malnutrition due to the presence of intestinal worms.

The national program is struggling to cover half of the districts endemic with the NTD LF with annual treatment, and coverage of the population within the treated districts is much lower than the targeted 80% coverage rate required to interrupt transmission.  It was over several more cups of tea that the public health officials shared openly with us their need for additional resources and technical support in order to scale up and reach all Bangladeshis at risk.

» Read more: Professor Yunus and 10 Cups of Tea in Bangladesh